Integrated Chinese and Western Medicine Brain Diseases Department

Department overview: The Neurology Department of Zhejiang Provincial Hospital of Traditional Chinese Medicine was independently established and opened its ward in 1992. A neurology ward opened at the Xiasha campus in 2002, and a neurological rehabilitation ward at the Xixi campus in January 2021; the three campuses now have 170 beds in total. Technical strengths: The hospital has advanced medical equipment, complete research facilities, mature research technology, and a large outpatient/emergency volume. The department has complete specialties and strong technical capacity, and has formed a systematic and complete integrated Chinese-Western neurological diagnosis-and-treatment system and a high-level TCM brain-disease team with a rational talent structure and clear direction. Its internationalized and evidence-based work on stroke, epilepsy, myasthenia gravis, and common, difficult, and critical neurological diseases and TCM brain disorders is at a leading domestic or international level. Academic status: It has successively been designated a key specialty of the State Administration of Traditional Chinese Medicine during the 11th and 12th Five-Year Plans, a key discipline of TCM in Zhejiang, a member institution of the National Brain Disease Collaborative Group, a clinical pharmacology base of the China Food and Drug Administration, a Stroke Center of the Chinese Stroke Association, an Epilepsy Center of the Chinese Association Against Epilepsy, a pilot institution for TCM brain health and cognitive-disorder prevention and treatment, deputy-chair institution of the Yangtze River Delta TCM brain-disease quality-control center, and a member of the Pan-Yangtze River Delta Neuromuscular Disease Alliance and the Yangtze River Delta TCM Brain-Disease Specialty Alliance.